Valerio Berardi

• • Filed patent for novel RNA biomarker in breast cancer diagnostics (US Application No.

• • Conducted customer discovery (I-Corps): 50+ stakeholder interviews across physicians, payers, patients

• • Engaged with oncologists and clinical opinion leaders to assess clinical utility and market needs

• • Developed scientific value proposition and clinical evidence requirements for diagnostic innovation

• • Negotiated licensing agreement with industry partner, managing complex stakeholder relationships

• • Gained practical understanding of healthcare business context and commercial decision-making

• • Evaluated therapeutic targets for RNA-specific autoantibodies in neuropsychiatric lupus, contributing to peer reviewed publication in Life Science Alliance

• • Collaborated with clinical rheumatology teams to translate molecular findings into therapeutic strategies

• • Presented research findings to clinical and basic science audiences at research seminars

• • Led breast cancer biomarker discovery project from concept through patent filing and licensing negotiation

• • Supervised graduate students and delivered lectures in molecular and cellular biology

• • Managed cross-functional research teams and coordinated with clinical collaborators

• • Experience with autoimmune disease mechanisms relevant to nephrology (lupus nephritis, kidney involvement in systemic autoimmune conditions

• • Developed high-throughput assay platform for therapeutic discovery in Amyotrophic Lateral Sclerosis (ALS)

• • Identified novel binding proteins (DARPins) for potential ALS therapeutics through systematic screening

• • Established collaborations with neurology departments and ALS clinical researchers

• • Launched novel cellular αSyn aggregation screening assay for neurodegenerative disease research

• • Presented research findings at international neuroscience conferences